LRRK2 and Parkinson disease: Advanced assay technologies: Ultrasensitive techniques, such as α-syn [23], RT-QuIC for skin and saliva [39,43], and SISCAPA for LRRK2 [54], can enhance the detection of low-abundance pathological forms, thereby increasing sensitivity for diagnosing prodromal and early stages of PD.